Phase 3 N=213 Buprenorphine for Prisoners
Heroin Addiction
Primary: Number of Days of Heroin Use — 6.0; 6.4; 6.5; 4.0 days
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=211 Methadone Maintenance for Prisoners
Heroin Addiction
Primary: Treatment Retention in the Community — 23.1; 91.3; 166.0 Days in community treatment
N/A N=69 PTSD Treatment for Incarcerated Men and Women: NIMH
PTSD
Primary: Number and Percentage of Participants That Attend All Offered Cognitive Processing Therapy Sessions — 31; 32 Participants
N/A N=100 Mental Health Services for Prisoners With SMI
Mental Disorder
Primary: Change in Levels of Aggression Score From Baseline to Month 3 — -4.81; -2.68 score on a scale
N/A N=403 Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration
Stress Disorders, Traumatic · Stress Disorders, Traumatic, Acute · Depressive Symptoms
Primary: Housing Stability — 17; 65; 7; 23 Participants
N/A N=51 Skin Camouflage for Women Prisoners With Self-Harm Scarring
Self Injurious Behaviour
Primary: Warwick-Edinburgh Mental Well-being Scale — 40.1739; 30.8182 score on a scale
N/A N=820 TYRO Couples Project Study
Couples
Primary: Primary Outcome Measure 1: Employment Attitudes — 4.16; 4.13 score on subscale
Phase 4 N=44 Relapse Prevention to Reduce HIV Among Women Prisoners
Opioid Dependence · HIV
Primary: Opiate Positive Urines With Missing Urines Coded as Positive at Week 12. — 14; 5 participants
Phase 4 N=450 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
Schizophrenia
Primary: Time to First Treatment Failure — 416; 226 Days
N/A N=100 Alcohol Pharmacotherapy for HIV+ Prisoners
Alcohol Dependence · Problem Drinking · Hazardous Drinking
Primary: Percentage of Those Maintain or Improve to HIV RNA-1 Viral Load Less Then 400 Copies/mL — 54; 42 percent of participants
N/A N=18 Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Open Trial
Bipolar Disorder
Primary: Client Satisfaction Questionnaire-8 (CSQ-8) — 27.90 score on a scale
N/A N=100 Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
HIV/AIDS · Pre-exposure Prophylaxis
Primary: Satisfaction of the Utilization of the CHW to Aid in Accessing PrEP Assessed by the Client Satisfaction Questionnaire-Revised — 29.5 Score on CSQ-8
N/A N=312 Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
Opioid Dependence · Addiction · HIV/AIDS
Primary: TB Treatment Completion Rates in Prison — 114; 127 Participants — p=0.08
N/A N=54 Monocentric Randomized Study, Assessing the Interests of the Determination of Vitamin D in Prison Population. (Vitamine D)
Male Prisoner
Primary: Dosage of Vitamin D — 28.2; 14.6 ng/mL — p=<0.001
N/A N=34 Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Pilot RCT
Bipolar Disorder
Primary: Client Satisfaction Questionnaire-8 (CSQ-8) — 28.00; 26.20 score on a scale
Phase 4 N=27 A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration
Opioid Dependence
Primary: Incidence of Subject Re-arrest — 6; 2 participants re-arrested — p=>0.05
N/A N=233 Mobile Enhanced Prevention Support for People Leaving Jail
HIV Infections · Sexually Transmitted Diseases, Bacterial · Hepatitis C
Primary: Number of Participants Establishing a Primary Care Provider Who Can Prescribe PrEP (Pre-exposure Prophylaxis) — 82; 90 Participants — p=0.780
N/A N=176 Post-release Retention in HIV Care for Ex-inmates in South Africa
Hiv · Adherence, Patient
Primary: Number of Participants in Care at Six Months — 67; 19 Participants